A 24-week, double-blind, randomized, parallel-group study evaluating the efficacy and safety of oral nintedanib co-administered with oral sildenafil, compared to treatment with nintedanib alone, in patients with idiopathic pulmonary fibrosis (IPF)

Administered By

Awarded By

Contributors

Start/End

  • November 1, 2016 - October 31, 2018